(-0.03%) 5 186.21 points
(0.39%) 39 036 points
(-0.19%) 16 301 points
(1.02%) $79.18
(-1.18%) $2.18
(-0.19%) $2 319.90
(0.23%) $27.61
(-0.33%) $985.10
(0.13%) $0.931
(0.05%) $10.90
(0.09%) $0.800
(0.17%) $91.59
-4.11% $ 130.45
@ $133.65
Emitido: 8 may 2024 @ 09:37
Retorno: -2.39%
Señal anterior: may 6 - 12:46
Señal anterior:
Retorno: -0.76 %
Live Chart Being Loaded With Signals
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases...
Stats | |
---|---|
Volumen de hoy | 894 403 |
Volumen promedio | 908 724 |
Capitalización de mercado | 12.33B |
EPS | $0 ( 2024-04-30 ) |
Próxima fecha de ganancias | ( $-0.0700 ) 2024-06-06 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 296.48 |
ATR14 | $7.67 (5.88%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-02 | Murray Dallan | Sell | 3 635 | Common Stock |
2024-04-24 | Murray Dallan | Sell | 0 | Common Stock |
2018-03-03 | Murray Dallan | Sell | 113 | Stock Option (Right to buy) |
2019-03-05 | Murray Dallan | Sell | 9 039 | Stock Option (Right to buy) |
2020-03-04 | Murray Dallan | Sell | 8 821 | Stock Option (Right to buy) |
INSIDER POWER |
---|
15.38 |
Last 99 transactions |
Buy: 338 836 | Sell: 333 998 |
Volumen Correlación
Sarepta Therapeutics Inc Correlación
10 Correlaciones Más Positivas | |
---|---|
TIG | 0.913 |
CPLP | 0.911 |
CCRC | 0.9 |
ORTX | 0.899 |
DSKE | 0.888 |
XLNX | 0.878 |
FXCO | 0.878 |
VIA | 0.876 |
HCCI | 0.875 |
FGFPP | 0.875 |
10 Correlaciones Más Negativas | |
---|---|
GCBC | -0.914 |
WINT | -0.912 |
EJH | -0.91 |
AGIL | -0.909 |
XPDI | -0.899 |
BJDX | -0.898 |
UTRS | -0.891 |
CNSP | -0.89 |
LHDX | -0.887 |
PCSA | -0.887 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Sarepta Therapeutics Inc Correlación - Moneda/Commodity
Sarepta Therapeutics Inc Finanzas
Annual | 2023 |
Ingresos: | $1.24B |
Beneficio Bruto: | $1.09B (87.91 %) |
EPS: | $-5.80 |
FY | 2023 |
Ingresos: | $1.24B |
Beneficio Bruto: | $1.09B (87.91 %) |
EPS: | $-5.80 |
FY | 2022 |
Ingresos: | $933.01M |
Beneficio Bruto: | $793.02M (85.00 %) |
EPS: | $-8.03 |
FY | 2021 |
Ingresos: | $701.89M |
Beneficio Bruto: | $604.84M (86.17 %) |
EPS: | $-5.15 |
Financial Reports:
No articles found.
Sarepta Therapeutics Inc
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; and VYONDYS 53 for the treatment of duchenne in patients with confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping. The company is also developing AMONDYS 45, a product candidate that uses phosphorodiamidate morpholino oligomer chemistry and exon-skipping technology to skip exon 45 of the dystrophin gene; SRP-5051, a peptide conjugated PMO that binds exon 51 of dystrophin pre-mRNA; SRP-9001, a DMD micro-dystrophin gene therapy program; and SRP-9003, a limb-girdle muscular dystrophies gene therapy program. It has collaboration agreements with F. Hoffman-La Roche Ltd; Nationwide Children's Hospital; Lysogene; Duke University; Genethon; and StrideBio. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico